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Abstract 
 
There is a significant need for data integration 
capabilities in the scientific domain, which has 
manifested itself as products in the commercial world 
as well as academia.  However, in our experiences in 
dealing with biological data it has become apparent to 
us that existing data integration products do not 
handle uncertainties in the data very well.  This leads 
to systems that often produce an explosion of less 
relevant answers which subsequently leads to a loss of 
more relevant answers by overloading the user.  How 
to incorporate functionality into data integration 
systems to properly handle uncertainties and make 
results more useful has become an important research 
question. 
  In this paper we describe an enhanced general-
purpose data integration system which incorporates 
uncertainty metrics within a formal probabilistic 
framework.  Additionally, for evaluation purposes, we 
have implemented a use case scenario which utilizes 
biological data sources and performed a study which 
provides validation of system query results. 
 
1. Introduction 
 
Unlike  more  “traditional” sources of data such as 
banking or inventory, biomedical scientific data is 
inherently uncertain.  This uncertain nature presents 
unique challenges in regards to its handling and 
manipulation, “information overload” being one 
example [1].  For us in particular, data uncertainties 
have made it difficult to apply data-integration (DI) 
technologies according to the wishes of our biological 
collaborators.  This challenge has led us down our 
current path, which is the incorporation of a formal 
framework for handling data uncertainty (uncertainty 
metrics) into a general-purpose federated DI system.   
To help illustrate uncertainty metrics and how they are 
applied to biological data, we provide examples of data 
uncertainty drawn from our own experiences.  Although 
what we provide are examples, we feel that they capture 
and classify general areas of uncertainty in biological 
data into two broad categories: 
1)  Inherent Data Uncertainties.  Inherent data 
uncertainties are attributes of the data itself and 
not artifacts of its representation. Data generated 
from laboratory experimental methods often 
have inherent uncertainties.  To illustrate an 
extreme case, two-hybrid screening assays, 
which are used to detect protein interactions, 
have error rates estimated to be close to 50% 
[2].  Experimental data can also be generated 
from computational (or “in-silico”) 
experiments.  The BLAST algorithm [3] 
searches in a database for sequences similar to a 
query sequence.  The similarity between any 
two sequences is measured by the BLAST “e-
value”, which is the degree to which the pairing 
could occur by chance.  Additionally, 
uncertainties can be rooted in the ever-evolving 
nature of biological knowledge itself.  For 
example, GenBank references sequences 
(RefSeq’s) are assigned “status codes” which 
refer to the amount of evidence and expert 
curation attributed to a given sequence and its 
function [4].  These codes range from “inferred” 
where there is little support for a given 
sequence, to “reviewed” where substantial 
evidence exists and has been vetted by a 
biological domain expert.  Status codes for 
sequences change over time as evidence for 
them accumulates. 
2)  Data Representation Uncertainties.  Data 
representation uncertainties result from the mapping of real world information onto a 
computable representation of this information. 
At last count there were over 600 online data 
sources in molecular biology [5].   
Unfortunately, for all the data that is available 
there are no common standards for representing 
it (in part due to the evolving nature of 
biomedical knowledge).  The result is the 
decentralized and heterogeneous nature of 
biological data sources which is an underlying 
source of many data uncertainties.  For instance, 
there is no common identifier for a biological 
object [6] which make it difficult to query 
across data sources (manually or otherwise), a 
task which is commonly performed.  Linkages 
between data records may then require string 
matches on text fields rather than more reliable 
“foreign-key” relationships.  Additionally, data 
sources tend to represent data in idiosyncratic 
fashion.  For example, GenBank uses RefSeq 
status codes to represent the level of evidence 
for a particular gene but the Gene Ontology 
(GO) uses evidence codes [7].  Given evidence 
from both sources, it is sometimes difficult to 
make comparisons, such as determining which 
code provides the greater weight of evidence. 
 
1.1. Functional Annotation of Proteins 
 
These uncertainties in biological data pose significant 
challenges to existing DI systems.  In conjunction with 
our biological collaborators, we applied DI technology 
to the task of assigning biochemical function to 
unknown protein sequences (functional annotation).   
Functional annotation is crucial to bioresearch and is 
fast becoming a high priority in the biological 
community due to the vast numbers of new proteins 
predicted from genome sequencing projects which 
require function assignment [8, 9].  Unfortunately, 
annotation is currently quite expensive in terms of time 
and human capital as it is a very manual process which 
requires a great deal of expertise due to its complex and 
often ambiguous nature.  Functional annotation is also 
highly dependant on various biological data sources 
which are developed in isolation and are thus very 
heterogeneous and dispersed.  One of the many 
challenges faced by biological researchers is querying, 
traversing and compiling data from a multitude of 
different sources (Figure 1).   
 
 
Figure 1. In the current paradigm for 
annotating proteins, biological researchers 
often compile data from various non-
interoperable sources manually (or use ad-hoc 
techniques) which greatly slows the pace of 
research (adapted and modified from [10]). 
 
To address this issue and drawing from our 
experience in integrating data sources for functional 
annotation, we were able to properly integrate a number 
of data sources using an existing data integration 
system (BioMediator) with the intent of creating an 
easily accessible annotation data resource for biological 
researchers but uncertainties in the data greatly affected 
the usability of the system by producing explosions of 
less relevant answers to queries.  This overwhelmed 
human users making it hard to find the most relevant 
answers.  This problem is rooted in the fact that protein 
annotation is knowledge-base driven.  What this means 
is that computational function assignment is dependant 
upon determining the “similarity” between a protein of 
unknown function and previously characterized 
proteins.  These similarity or classification functions are 
inherently probabilistic in nature, Hidden Markov 
Models for determining protein family classification 
being one example (Pfam [11]).  In many cases, 
multiple results are returned from each individual 
source and it can be difficult, for a data integration 
system as well as a human, to determine what the best 
result is from a particular source or among several 
sources (Figure 2).  Generally speaking, however, the 
result with the strongest overall similarity score 
deserves the most attention as it is likely the most 
probable annotation for a given protein, given the 
caveats that similarity scores may not be totally 
comparable between sources.  We determined that a 
possible approach to addressing the issue of winnowing 
out good results from a data integration perspective 
would be to include functionality in the DI system 
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PSORTwhich would allow it to handle uncertainties in the data.  
This would enable it to perform functions such as 
highlighting only the most relevant data by presenting 
results as a ranked list.   
 
 
Figure 2. Simplified example of an integrated 
result set of annotation data output from the 
BioMediator system when queried with S. 
oneidensis reference protein SO0265 (center 
of graph).  There are many related results from 
multiple individual data sources with results 
such as “Tetratricopeptide repeat” or “nrfG” 
(a gene name).  The result which agrees with 
the reference annotation however is from 
COG4235 (arrow) the description of which is 
“Cytochrome c biogenesis factor”.  This 
disagrees with many of the results from the 
other sources and it would be difficult for an 
annotator to select this result from all the 
others without some mechanism to highlight 
more relevant results (based on common 
metrics. 
 
In this paper we discuss our approach to 
incorporating a formal framework for handling data 
uncertainties into a general-purpose data integration 
system.  In addition we have carried out an initial study 
which validates that our system can produce ranked 
lists of results which are meaningful to a biological 
domain expert. 
 
2. Data Model 
 
2.1. The BioMediator Data Integration System 
 
The BioMediator system, developed at the 
University of Washington, was designed as a tool for 
integrating syntactically and semantically heterogenous 
data while maintaining data source autonomy.   
Although it has been particularly applied in the 
biological domain, the system is general-purpose [12-
18] and freely available (www.biomediator.org). 
 
2.1.1. Background:  BioMediator Architecture.   
BioMediator is a mediated schema distributed data 
integration system.  It provides a unified, uniform view 
over a network of inter-related data sources.  Source 
object types (e.g. EntrezGene_Gene and 
SwissProt_Protein) are aligned across sources by 
mapping them to common object types within the 
mediated schema (e.g. Gene and Protein respectively).  
A query result object (i.e. a specific Gene record) 
returned by the system is uniquely identified by its 
mediated schema type, data source, and source uid. 
BioMediator exposes query result sets using an 
annotated directed graph data model.  Nodes in this 
graph represent source records, returned during the 
query process, transformed into objects in the mediated 
schema space.  Nodes are annotated with their 
appropriate attribute values (such as schema object 
type, source, and uid).  Edges in the graph represent 
cross-references from one node (result object) to 
another.  Such references may be explicitly represented 
in the head node (“foreign key” references) or they 
may be derived by the system (see Query Model 
below). 
 
2.1.2. Query Model in BioMediator.  BioMediator 
employs an exploratory, browser-based query model.  
Users first initiate a seed query, which is constructed 
by specifying the desired object type from the 
mediated schema and desired attribute-value 
constraints (e.g. Gene:symbol=’BRCA1’).  The system 
queries all sources with mappings to the corresponding 
object type and retrieves from them records satisfying 
the given constraints.  The initial result graph is 
represented as a set of result nodes linked from a 
system node representing the seed query (see Figure 3).  
Through a process called query expansion, users select 
any subset of nodes from the current result graph for 
further exploration.  The system attempts to join the 
selected nodes with related records from the source 
network.  This process may include following foreign 
key references from a selected node, querying sources 
in the network that might themselves have foreign key 
references back to a selected node, or performing inter-
source record alignment by matching values found in 
non-key fields.  Depending on the sources involved, 
these latter types of alignments may employ partial 
matching algorithms. While the set of nodes to be expanded can be 
explicitly selected by the user, there is also an “expand 
all” option.  As the name implies, expand all triggers a 
query expansion over the set of all current result nodes.  
As new result nodes are added to the result graph, new 
edges are also added to illustrate the inter-node 
referential links.  Figure 4 shows a portion of a result 
graph after performing an expand all operation on the 
seed result graph from Figure 3.   This figure visually 
suggests the data overload problem that can ensure 
from an exploratory graph model.  For more details on 
our browser-based query model, please see [13]. 
 
 
Figure 3. Seed query (BRCA1 gene name, 
center of graph) and initial results after one 
expand all operation. 
 
 
Figure 4. Partial view of result graph of seed 
query (BRCA1 gene name) showing results 
from multiple sources after 3 expand all 
operations.  The size of the result set quickly 
becomes difficult for a human to analyze. 
 
2.2. Data Uncertainties in BioMediator 
 
2.2.1. Uncertainty Extensions.  In this work, we have 
embarked on a new approach by extending the 
BioMediator data and query models to better support 
the handling of uncertainty in the data integration 
process for the overall purpose of making result sets 
more useful. 
 
2.2.2. Uncertainty Metrics.  Uncertainty metrics 
provide a framework in BioMediator for describing 
such things as the quality of data sources, quality of 
cross-references (links) between sources, and the 
quality of the data entities themselves and links 
between them.  The uncertainty metrics are interpreted 
probabilistically and are stored as annotations on the 
result graph.  The system then calculates relevance 
scores for each query result which allow results to be 
ranked, enabling users to identify the most useful 
results.  The following is a summary description of the 
four fundamental uncertainty metrics that capture all 
types of uncertainty in the BioMediator system: 
1)  Ps measure:  A quantification of a user’s prior 
belief in the quality of data records of a 
particular mediated schema type from a 
particular data source (e.g. Genes from Entrez 
Gene, Classifications from Entrez Gene, and 
Classifications from GO, are each assigned Ps 
values).  Ps sets the maximum belief threshold 
for any particular data record of the 
corresponding type and source.  For example, 
consider the comparison between proteins 
from SwissProt and TrEMBL.  SwissProt is a 
manually and carefully curated data source of 
protein functional information whereas 
TrEMBL contains only computational 
predictions which are deemed less reliable.   
The class of protein records from SwissProt 
therefore should be assigned a higher Ps value 
than those from TrEMBL because SwissProt 
protein records are generally trusted to a 
greater degree. 
2)  Qs measure:  A quantification of a user’s 
prior belief in the quality of a particular 
relationship type from the mediated schema 
where a relationship type asserts the schema 
type and source of both the head and tail 
records (e.g. Genes in Entrez Gene to Proteins 
in Entrez Protein).  Qs sets the maximum 
belief threshold for any particular data link 
whose head and tail records are of the 
corresponding types and sources.  To 
elaborate, records in some sources, such as 
Gene records from Entrez Gene, contain references to records in another source, such 
as  Protein records from Entrez Protein.  In 
this example, these references are in the form 
of “accession” numbers which essentially 
correspond to unique identifiers (foreign-
keys).  Records between other types and 
sources however may only be connected by 
non-foreign keys, e.g. text-string similarities 
such as is the case between Genes from 
Entrez Gene and Genes in OMIM.  In this 
example, the relationship between Genes in 
Entrez Gene and Proteins in Entrez Protein 
should be assigned a higher Qs value since 
these links are better in general than those 
between Genes in Entrez Gene and Genes in 
OMIM. 
3)  Pr measure:  This is a quantification of a 
user’s belief in a particular data record.   
Unlike the Ps measure, the Pr measure is 
calculated at the time a particular result is 
returned from a particular source.  It is used to 
capture data uncertainties which differ 
between records of the same type and source.  
Gene records in Entrez Gene, for example, are 
attributed with a Refseq status code which 
ranges in value from “inferred” to “reviewed”.  
These status codes correspond to the amount 
of evidence for a given gene, therefore 
“reviewed” should be assigned a higher Pr 
value than “inferred”. 
4)  Qr measure:  This is a quantification of a 
user’s belief in a particular cross-reference 
(link) between two data records.  Like Pr, it is 
dynamic (calculated at the time two linked 
results are returned by the system).  For 
example, record cross-references using unique 
identifiers always receive a Qr of 1.0.  Some 
records may reference others via the use of 
comparison algorithms such as BLAST.  For 
BLAST cross-references Qr’s are dynamically 
computed by converting the e-value from the 
BLAST algorithm into a numeric value 
between 0.0 and 1.0.  BLAST comparisons 
which correspond to better “matches” 
between records (higher similarity) receive 
higher Qr values. 
 
2.2. Probabilistic Query Evaluation 
 
The uncertainty metrics discussed thus far have all 
been local measures.  They are calculated and applied 
to nodes and edges irrespective of their position in the 
greater result graph.  The information we are seeking, 
however, is a global measure of the relevance of each 
node to the original seed query.  Such a relevance 
measure should be based on the uncertainties of nodes 
and edges along all paths connecting the seed query 
node to the target node.  To help us solve this problem, 
we recast it in terms of a network reliability problem 
[19]:  For each result node n1, Psn1 * Prn1 is interpreted 
as the probability that the node is currently present in 
the network.  Likewise Qse1 * Qre1 is viewed as the 
probability that a given network link e1, is available.  
We calculate the relevance of a node as the probability 
that the node is reachable from the seed node in our 
network reliability problem. 
 
2.3. Relevance Evaluation Algorithm 
 
2.3.1. Relevance score calculation.  The problem is as 
such:  given a directed graph with probabilistic scores 
on nodes and edges, compute for each node the 
probability that there is a path from the start (seed) 
node to any given result node.  Computation of exact 
probability scores is intractable but can be efficiently 
approximated to arbitrary precision using simulation 
algorithms [20].  In our case, we simulate in a single 
pass N trials (path traversals) where nodes and edges 
are included in the traversal with associated 
probabilities.  This is performed by storing a 
randomized N-bit trial vector associated with each 
node and edge, where each bit is a binary value 
denoting success or failure of a particular trial (based 
on the uncertainty metrics).  In a depth first search of 
the graph beginning from the seed node, we populate a 
success vector for each node indicating for each trial 
whether or not that node is reachable by some path (i.e. 
the path contains only nodes and edges included in this 
trial).  For each node a count (k) is maintained which is 
the number of times it could be reached, via some path, 
over the total number of trials.  The final score, or 
relevance, for a node is then estimated using the 
quantity  k/N, where k is the number of set bits in a 
node’s success vector.  Because this is an 
approximation algorithm, the choice of N influences 
the error in the estimation and the larger the N, the 
smaller the error.  Also, for any fixed value of N, the 
greater the actual relevance of a particular node, the 
better the approximation will be.  Overall, the 
algorithm should correctly rank the most relevant 
answers (which are the most important), whereas the 
poorest results may be slightly out of order. 
 
2.3.2. Relevance Score Measure.  The final relevance 
score of a node is simply the probability that the node 
can be reached from the seed node, e.g. the probability 
that there is a path from the seed node to any particular 
result node.  Figure 5 illustrates an example of a result with various nodes annotated with uncertainty metrics 
and relevance (UII) scores.  Relevance scores are 
useful in that entity sets can be sorted accordingly and 
results presented to users as ranked lists. 
 
 
Figure 5. Same result graph as in Figure 2 for 
S. oneidensis protein SO0265 (center of 
graph) with some results annotated with 
examples of uncertainty metrics (Ps, Pr) and 
final relevance scores (UII).  The highest 
relevance score generated by the system is 
from COG4235 (description agrees with the 
reference annotation) because in this 
example, COG4235 has the best quality path 
from the query node.  The relevance score can 
be utilized by the system to rank, highlight, or 
filter in order to enable annotators to select 
the best results.  
 
3. Experimental Results 
 
3.1. Experimental Setup 
 
3.1.1. Use Case.  To validate query results we 
implemented a simple functional annotation use case 
based on the classification of proteins from the 
Clusters of Orthologous Groups (COG) database [21].  
The COG database organizes known proteins into 
groups according to general biochemical function 
(COGs) based on sequence similarity.  Biologists often 
assign a biochemical function to an unknown protein 
by submitting it as a query to the COG database which 
subsequently compares the sequence of the unknown 
protein to the various COGs and returns results (often 
multiple).  Each result carries with it biochemical 
function information about the COG as well as a 
probabilistic similarity measure (e-value) of the COG 
to the query protein.  The rationale here is that given a 
protein with an already known COG assignment, the 
system should be able to take that protein as a query 
and reproduce the actual COG assignment by ranking 
it at the top of a results list.  Therefore, a set of 32 
proteins with known and pre-defined biochemical 
functions were chosen according to the 25 functional 
categories in the COG database (e.g. transcription, cell 
cycle, etc.) with the help of a collaborating biologist.  
These served as the “gold-standard” by which the 
system queries were evaluated. 
 
3.1.2. BioMediator.  An initial set of functional 
annotation data sources were identified by our 
biological collaborators.   There are:  AmiGO [22], the 
Conserved Domain Database (CDD [23]), Entrez Gene 
and Entrez Protein [24], Pfam [25], SuperFamily [26], 
the BLAST database at the NCBI, the PSI-BLAST 
database at the DDBJ, PDB [27], and UniProt [28].  
Note that some of the data sources are themselves 
aggregates of sources.  For instance, CDD contains 
Pfam, SMART [29], COG, as well as its own 
proprietary information.  UniProt contains SwissProt, 
and TrEMBL [30].  Appropriate data entities, 
attributes, and their relationships were identified and 
modeled in the mediated schema.  It was deemed 
important to test queries on multiple data sources to 
ensure that:  1) all uncertainty metrics were populated 
correctly, and 2) relevance scores were calculated 
correctly for all data entities.  It would be a better test 
of the system, for example, if COG rankings were 
evaluated using result sets which included data from 
multiple sources rather than just the COG. 
 
3.1.3. Population of Uncertainty Metrics.  All 
entities from sources in the federation were considered 
to be of equivalent quality, thus Ps values for all were 
set to 1.0.  Qs values were also all set to 1.0 since links 
between all sources were either “foreign-key” cross-
references or comparison algorithms (which are 
handled by the Qr metrics).  Other metrics were 
determined from data type descriptions of individual 
data sources (e.g. some data sources explicitly say 
which data to trust more) and also in discussions with 
domain experts as to their opinion of what data was 
most relevant to them for the particular task of 
annotating proteins.  These initial uncertainty metrics 
were meant to serve as prototypical examples with 
which to test the calculation of relevance scores by the 
system and provide generally meaningful results for 
evaluation purposes.  Tables 1 and 2 provide selected 
Pr and Qr values incorporated in the system, not all the 
metrics were evaluated in this study but are provided 
here for the purposes of illustration: 
Ps: 1.0 
Pr: 0.7 
UII: 0.05 
Ps: 1.0 
Pr: 0.8 
UII: 0.35 
Ps: 1.0 
Pr: 0.8 
UII: 0.26  
Table 1. Pr belief values for entity types.  
Attempts were made to assign identical Pr 
values to entity attributes with similar 
meaning such “TAS” (Traceable Author 
Statement) and “Reviewed” which both 
suggest some involvement by a human 
annotator. 
Entity Attribute  Calculation 
Gene  Status Code  Reviewed (1.0) 
Validated (0.8) 
Provisional 
(0.7) 
Predicted (0.4) 
Model (0.3) 
Inferred (0.2) 
Classification  Evidence Code  IDA (1.0) 
TAS (1.0) 
IGI (0.9) 
IMP (0.9) 
IPI (0.9) 
IEP (0.7) 
ISS (0.7) 
RCA (0.7) 
IC (0.6) 
NAS (0.5) 
IEA (0.3) 
ND (0.2) 
NR (0.2) 
Domain, COG  Description  Curated (1.0) 
Alignment from 
Source (0.5) 
 
Table 2. Qr belief calculations for selected 
entity relationship types. There is also a range 
check which assigns a Qr of 0.0 or 1.0 if the 
result of the calculation is less than 0.0 or 
greater than 1.0 respectively. 
Relationship Attribute  Calculation 
Protein -> 
Domain 
Protein -> 
COG 
Protein -> 
Protein 
e-value 
expect  ()






200
log10 evalue
abs  
 
3.1.4. Evaluation.  The 32 gold-standard proteins were 
submitted to the system which subsequently queried all 
databases in its federation (including the COG), 
populated belief values for all data entities, calculated 
relevance scores, and returned results as ranked lists.  
The functional category of the highest ranking COG in 
a result set from the system was then compared to the 
actual COG functional category from the gold-standard 
protein.  The evaluation methodology is a simple 
percent agreement between the top ranking COG in the 
system versus the COG category from the gold-
standard protein. 
 
3.2. Results 
 
The 32 gold-standard proteins with pre-assigned 
COG functional categories were submitted as seed 
queries to the system and subjected to query expansion.  
All data sources in the federation were queried 
successfully, belief values for all data entities 
populated correctly, relevance scores calculated, and 
results returned as ranked lists of entities.  Of the 32 
seed proteins, 14 had only a single result from the 
COG.  These were omitted from the final analysis 
because no ranking was necessary (although this did 
mean that the system produced a correct answer by 
default).  The top COG result from each of the 
remaining 18 proteins was selected, the COG 
functional category determined and subsequently 
compared with the gold-standard COG category of the 
protein.  The initial agreement between the COG 
category from the system and the gold-standard COG 
category was 77.8% (14/18).  However, upon further 
inspection it was discovered that three of the gold-
standard proteins were actually assigned to two COG 
functional categories and the system had actually 
correctly ranked at least one of them.  These three 
results were then converted to successes which 
increased the agreement to 94.4% (17/18).  The 
remaining disagreement was inspected and it was 
determined that the reason for the incorrect result was 
due to the approximating nature of the relevance score 
calculation.  After adjusting a parameter in the 
algorithm (increasing the number of trials) and re-
submitting the query, the top-ranking COG in the 
system turned out to be the correct one, bringing the 
total agreement to 100% (18/18). 
 
4. Observations 
 
The study results, although preliminary, are 
encouraging and strongly suggest that our formal 
framework is performing adequately by quantifying the 
quality of result sets and ranking them according to a 
biologically significant metric.  In regards to the single 
case where the system produced an incorrect ranking, a 
deeper analysis revealed that the query protein 
(GenBank Accession #: NP_717854) had by far the 
largest number of results from the CDD database 
(approximately 100).  Additionally, the number of 
trials set in the approximating algorithm was set to 
1000, a fairly low initial number to ensure fast calculation of relevance scores.  When this parameter 
was increased (to 50,000) the additional simulation 
precision allowed the system to consistently rank the 
correct COG for the protein.  This did impact the 
performance of the system however as the (observed) 
time to calculate relevance scores increased 
significantly (seconds, to minutes).  The negative 
impact of having to increase the trial parameter on the 
tractability of the relevance score algorithm has 
illuminated the need for us to explore alternative 
methods to calculating relevance scores. 
The approximating algorithm itself, as previously 
mentioned in Section 2, is based upon Network 
Reliability Theory (NRT) [19].  In NRT, the reliability 
of nodes is affected by the quality and number of paths 
to that node.  Generally speaking, the reliability of a 
node is high if there exists a high-quality path to the 
node or there exists multiple paths to the node 
(convergences).  In analogous fashion, data entities in 
our system can (theoretically) obtain a high relevance 
score if they are connected to the seed query by a high-
quality path or if multiple paths from the seed query 
converge on the data entity.  A limitation of our 
validation study is that we only evaluate single paths of 
evidence and not convergences, e.g. there is only a 
single path of data entities from the seed query protein 
to a particular COG result.  A study which evaluates 
results from the system where convergences are 
possible would be extremely interesting but, as it turns 
out, problematic to perform due to sparse usage of 
controlled terminologies (such as GO) by biological 
data sources.  For example, it is difficult to determine 
if two sources attribute the same biochemical function 
to a particular protein as one may use a synonym.   
Unless the system can determine that a particular 
biochemical function is a synonym of another, the 
paths from the two data sources will not converge.  The 
use of controlled vocabularies by biological data 
sources is steadily improving however so an evaluation 
may be possible in the not-too-distant future.  Also, 
calculating relevance scores by simple chaining is 
proving to be quite valuable in and of itself.  For 
instance, biological domain experts often assess the 
quality of BLAST results by a single metric (the e-
value).  The framework of our system allows for the 
use of additional metrics such as whether or not the 
result protein has experimental evidence for its 
function (highly relevant to a biologist) and rank 
results based on the e-value and the presence or 
absence of experimental evidence as well, something 
that is not currently possible with existing interfaces to 
BLAST. 
Uncertainty metrics in our system, while useful, do 
pose additional challenges for anyone attempting an 
implementation.  For one, it is often difficult to 
determine the appropriate attributes of data records for 
Pr and Qr values or the attributes may not be in a 
usable format.  GenBank protein records, for instance, 
have an “experimental evidence” tag.  This is an 
optional tag so it is often not present.  When it is 
present, using it to determine appropriate Pr values can 
still be difficult since its value is uncontrolled free text.  
Also, we have determined the values of our uncertainty 
metrics through expert opinion and not via quantitative 
machine learning techniques so it certainly possible 
that the values may not be generally applicable for 
other user bases.  Determining the values for all 
uncertainty metrics would be a difficult task however 
given the heterogeneity and volume of data.  Instead, 
as we mention in future directions, we are planning on 
doing a sensitivity analysis to determine the robustness 
of our UII score calculation to variations in uncertainty 
metrics.  Finally, uncertainty metrics add another layer 
of complexity when creating relationships between 
data entities in the mediated schema as this affects the 
calculation of relevance scores.  For example, certain 
biological data sources use algorithmic means to assign 
a biochemical function to a protein on-the-fly.  Protein 
records themselves however, may store pre-generated 
references to biochemical functions generated from the 
same source.  If both relationships are represented in 
the mediated schema this can lead to what is essentially 
“double-counting” of evidence which can lead to 
artificial inflation of the relevance score.   
Unfortunately, in our experience, it is often difficult to 
account for this as it is not always possible to 
determine the provenance of any particular data 
element in biological data sources. 
 
5. Related Work 
 
Not a great deal of work has been done on 
incorporating uncertainty metrics into data integration 
systems.  Trio [31], and Mystiq [32] are projects whose 
goal is to build probabilistic database systems but both, 
however, are focused on creating a centralized 
database and not an information integration system.  Of 
the data integration systems specifically developed to 
d e a l  w i t h  b i o l o g i c a l  d a t a  s u c h  a s  S R S ,  K l e i s l i ,  a n d  
Taverna [33-35], none deal with uncertainties in the 
data. 
 
6. Conclusions & Future Directions 
 
Limitations aside, the results of this study indicate 
that our work in incorporating data uncertainty metrics 
into a general-purpose data federated data integration 
system is foundationally solid and has potential for 
real-world application in assigning biochemical function to proteins.  While it is true that the results in 
this study focus on validating results from a single data 
source, a subsequent study which evaluates results 
from multiple data sources for functional annotation is 
currently in progress.  As potential future work we plan 
on implementing and evaluating alternative algorithms 
for calculating relevance scores to address the 
tractability issues we have encountered using our 
current algorithm, which uses simulation techniques 
and tends to require a large number of trials in order to 
reach a level of precision sufficient for our needs.  We 
also plan on further evaluating the performance of our 
current approximating algorithm by carrying out a 
sensitivity analysis to determine how sensitive the final 
relevance scores are to various changes in selected 
uncertainty metrics.  Results from this analysis will 
give us an idea of how “accurate” the uncertainty 
metrics must be to provide generally correct relevance 
scores.  If the relevance scores turn out to be generally 
robust then efforts to quantitatively determine the 
uncertainty metrics, such as using machine learning 
techniques, may be unnecessary.  Additionally, rather 
than use relevance scores to simply rank results, we 
would like to use them earlier in the query expansion 
process to limit the build-up of large result sets.  This 
should also improve the performance of the system 
overall by enabling the system to follow the most 
highly relevant paths early in the query process. 
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